[Diagnostic indications on phototoxic and photoallergic skin changes].
D000891:Anti-Infective Agents, Local / Q000009:adverse effects; D000935:Antifungal Agents / Q000009:adverse effects; D002400:Cathartics / Q000009:adverse effects; D003937:Diagnosis, Differential; D004232:Diuretics / Q000009:adverse effects; D004485:Eczema / Q000175:diagnosis*; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007004:Hypoglycemic Agents / Q000009:adverse effects; D008027:Light / Q000009:adverse effects*; D010787:Photosensitivity Disorders; D012871:Skin Diseases / Q000175:diagnosis / Q000209:etiology*; D013449:Sulfonamides / Q000009:adverse effects
D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D002400:Cathartics; D004232:Diuretics; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D007004:Hypoglycemic Agents; D013449:Sulfonamides
Diagnostische Hinweise auf phototoxisch und photoallergisch bedingte Veränderungen der Haut